Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

Many cancer patients prefer using telemedicine over in-person visits when completing the informed consent process, a study suggests.

Urodynamics investigation to identify detrusor overactivity before proceeding to invasive overactive bladder treatments do not appear helpful.

(HealthDay News) — Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a ...

Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.

(HealthDay News) — The U.S. Senate has confirmed the appointment of Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & fragmented healthcare.

Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.